Arrivent Biopharma logo

Arrivent Biopharma Share Price (NASDAQ: AVBP)

$19.17

-0.04

(-0.21%)

Last updated on

Check the interactive Arrivent Biopharma Stock chart to analyse performance

Arrivent Biopharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$18.75
    Today's High:$19.18

    Day's Volatility :2.24%

  • 52 Weeks Low:$15.47
    52 Weeks High:$36.37

    52 Weeks Volatility :57.46%

Arrivent Biopharma Stock Returns

PeriodArrivent Biopharma, Inc.Index (Russel 2000)
3 Months
-13.05%
0.0%
6 Months
-13.16%
0.0%
1 Year
-26.42%
0.0%
3 Years
-4.35%
-4.7%

Arrivent Biopharma, Inc. Key Stats

Check Arrivent Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$19.21
Open
$18.8
Today's High
$19.18
Today's Low
$18.75
Market Capitalization
$779.3M
Today's Volume
$225.2K
52 Week High
$36.37
52 Week Low
$15.47
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-4.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.06%

Stock Returns calculator for Arrivent Biopharma Stock including INR - Dollar returns

The Arrivent Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arrivent Biopharma investment value today

Current value as on today

₹77,001

Returns

₹22,999

(-23%)

Returns from Arrivent Biopharma Stock

₹28,283 (-28.28%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Arrivent Biopharma Stock

-80%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Arrivent Biopharma Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Arrivent Biopharma Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Arrivent Biopharma(by analysts ranked 0 to 5 stars)

Arrivent Biopharma Share Price Target

What analysts predicted

Upside of 106.34%

Target:

$39.56

Current:

$19.17

Arrivent Biopharma share price target is $39.56, a slight Upside of 106.34% compared to current price of $19.17 as per analysts' prediction.

Arrivent Biopharma Stock Insights

  • Price Movement

    In the last 7 days, AVBP stock has moved down by -4.9%
  • AVBP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 98.3%

Arrivent Biopharma Technicals Summary

Sell

Neutral

Buy

Arrivent Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Arrivent Biopharma, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Arrivent Biopharma, Inc. logo
-1.95%
-13.16%
-26.42%
-4.35%
-4.35%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Arrivent Biopharma, Inc.

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company's lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Organization
Arrivent Biopharma
Employees
52
CEO
Dr. Zhengbin Yao Ph.D.
Industry
Miscellaneous

Key Management of Arrivent Biopharma, Inc.

NameTitle
Dr. Zhengbin Yao Ph.D.
Co-Founder, Chairman, President & CEO
Dr. Stuart Lutzker M.D., Ph.D.
Co-Founder, President of Research & Development and Director
Mr. Winston Kung M.B.A.
CFO & Treasurer
Ms. Robin LaChapelle M.A.
Co-Founder & COO
Ms. Yang Wang Ph.D.
Chief Technology Officer
Dr. James Paul Kastenmayer J.D., Ph.D.
General Counsel & Secretary
Ms. Meghna Chowdary
Senior Vice President of Commercial Strategy

Important FAQs about investing in AVBP Stock from India :

What is Arrivent Biopharma share price today?

Arrivent Biopharma share price today is $19.17 as on at the close of the market. Arrivent Biopharma share today touched a day high of $19.18 and a low of $18.75.

What is the 52 week high and 52 week low for Arrivent Biopharma share?

Arrivent Biopharma share touched a 52 week high of $36.37 and a 52 week low of $15.47. Arrivent Biopharma stock price today i.e. is closed at $19.17, lower by 47.29% versus the 52 week high.

How to invest in Arrivent Biopharma Stock (AVBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arrivent Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arrivent Biopharma Shares that will get you 0.0782 shares as per Arrivent Biopharma share price of $19.17 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Arrivent Biopharma Stock (AVBP) from India?

Indian investors can start investing in Arrivent Biopharma (AVBP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Arrivent Biopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Arrivent Biopharma share’s latest price of $19.17 as on August 30, 2025 at 1:29 am IST, you will get 0.5216 shares of Arrivent Biopharma. Learn more about fractional shares .

What are the returns that Arrivent Biopharma has given to Indian investors in the last 5 years?

Arrivent Biopharma stock has given -4.35% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?